USANA Health Sciences, Inc.
USNA · NYSE
12/28/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $42,060 | $63,788 | $69,350 | $116,505 |
| Dep. & Amort. | $22,229 | $20,395 | $21,410 | $22,193 |
| Deferred Tax | -$6,744 | -$2,749 | -$7,183 | -$2,970 |
| Stock-Based Comp. | $14,558 | $14,595 | $13,485 | $14,298 |
| Change in WC | -$13,003 | -$27,999 | $771 | -$28,860 |
| Other Non-Cash | $1,892 | $2,611 | $6,069 | $61 |
| Operating Cash Flow | $60,992 | $70,641 | $103,902 | $121,227 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,073 | -$14,494 | -$10,400 | -$12,763 |
| Net Acquisitions | -$203,336 | $0 | -$6,532 | -$1,935 |
| Inv. Purchases | -$870 | -$1,271 | $0 | -$1,555 |
| Inv. Sales/Matur. | $1,125 | $3,775 | $4,555 | $1,935 |
| Other Inv. Act. | $64 | $15 | $7 | $131 |
| Investing Cash Flow | -$213,090 | -$11,975 | -$12,370 | -$14,187 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $22,220 | $792 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$9,444 | -$11,599 | -$25,382 | -$177,837 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,223 | -$3,430 | -$4,706 | -$3,575 |
| Financing Cash Flow | $9,553 | -$14,237 | -$30,088 | -$181,412 |
| Forex Effect | -$6,193 | -$2,503 | -$13,777 | $2,088 |
| Net Chg. in Cash | -$148,738 | $41,926 | $47,667 | -$72,284 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $333,246 | $291,320 | $243,653 | $315,937 |
| End Cash | $184,508 | $333,246 | $291,320 | $243,653 |
| Free Cash Flow | $50,919 | $56,147 | $93,502 | $108,464 |